Nowadays practically all pathogenic bacteria and viruses have developed resistance to most clinically important medicinal preparations, hence, there is a need in new drugs acting on new targets and being active against superbugs - resistant strains of pathogens [1]. Recently we have synthesized 2’-deoxypyrimidine nucleoside derivatives bearing extended alkyloxymethyl or alkyl(1,2,3-triazol-1-yl)methyl substituents at С-5 position and demonstrated their effective bacteriostatic activity against two Mycobacterium tuberculosis strains [2] as well as against a set of Gram-positive bacteria [3]. However, the nucleosides with large hydrophobic fragments are insoluble in water, thus, limiting the biological investigations. To solve this problem, a linker group was introduced for coupling a nucleoside moiety to a nanoparticle. At the same time, we have developed fundamentally new nanostructures of the type “Plates” with both positive and negative surface charge [5] with uniquely high optical properties (narrow fluorescence peak, high extinction, high efficiency of two-photon excitation) and offered an efficient method for obtaining conjugates [nucleoside-nanoparticle]. To study the effect of nanostructures on bacterial cells were selected bacteria that differ in shape, structure and thickness of the cell wall. Herein we will present a new approach for transporting medicinal agents into bacterial cells to their targets, namely, the preparation of conjugates of biologically active nucleosides with nanoparticles.